Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference
SAN DIEGO, May 7, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the BofA Securities 2024 Health Care Conference at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time) on Tuesday May 14, 2024 in Las Vegas. Kevin Gorman, Chief Executive Officer, Matt Abernethy, Chief Financial Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the conference.
OPEN WEBCAST
Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results
SAN DIEGO, Apr. 10, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its first quarter 2024 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on May 1, 2024.